Steven Cohen Acadia Pharmaceuticals Inc Transaction History

Point72 Asset Management, L.P.

$44.6 Billion
Q2 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 3,172,511 shares of ACAD stock, worth $75.3 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

3,172,511

Previous 4,647,816 31.74%

Holding current value

$75.3 Million

Previous $77.2 Million 11.36%

% of portfolio

0.15%

Previous 0.19%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$14.1 - $22.95 $20.8 Million - $33.9 Million	-1,475,305 Reduced 31.74%	3,172,511 $68.4 Million
Q1 2025 May 15, 2025	BUY	$16.61 - $20.29 $40.1 Million - $49 Million	2,417,001 Added 108.35%	4,647,816 $77.2 Million
Q4 2024 Feb 14, 2025	BUY	$14.29 - $18.76 $31.9 Million - $41.9 Million	2,230,815 New	2,230,815 $40.9 Million
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $42.9 Million - $54 Million	2,933,440 Added 377.68%	3,710,140 $60.3 Million
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $6.83 Million - $11.8 Million	383,873 Added 97.72%	776,700 $14.4 Million
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $7.11 Million - $10.9 Million	342,184 Added 675.68%	392,827 $12.3 Million
Q3 2023 Nov 14, 2023	SELL	$20.84 - $33.47 $17.5 Million - $28.2 Million	-841,283 Reduced 94.32%	50,643 $1.06 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $4.14 Million - $5.96 Million	232,420 Added 35.24%	891,926 $21.4 Million
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $7.45 Million - $9.55 Million	-456,394 Reduced 40.9%	659,506 $12.4 Million
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $15.8 Million - $20.8 Million	1,115,900 New	1,115,900 $17.8 Million
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $16.9 Million - $23.3 Million	-411,095 Reduced 71.1%	167,100 $8.93 Million
Q3 2020 Nov 16, 2020	BUY	$36.42 - $57.0 $13.8 Million - $21.6 Million	379,685 Added 191.27%	578,195 $23.9 Million
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $7.79 Million - $10.5 Million	198,510 New	198,510 $9.62 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $21.2 Million - $31.5 Million	-671,009 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $24.3 Million - $34.5 Million	671,009 New	671,009 $28.7 Million
Q3 2019 Nov 15, 2019	SELL	$22.22 - $44.01 $35,552 - $70,416	-1,600 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $9.09 Million - $11 Million	-389,928 Reduced 99.59%	1,600 $43,000
Q1 2019 May 15, 2019	SELL	$16.17 - $27.38 $30 Million - $50.8 Million	-1,855,072 Reduced 82.57%	391,528 $10.5 Million
Q4 2018 Feb 14, 2019	BUY	$14.32 - $22.92 $6.3 Million - $10.1 Million	439,600 Added 24.33%	2,246,600 $36.3 Million
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $16.8 Million - $28.1 Million	-1,287,501 Reduced 41.61%	1,807,000 $37.5 Million
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $19 Million - $28.2 Million	-1,262,925 Reduced 28.98%	3,094,501 $47.3 Million
Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $44.1 Million - $63.4 Million	1,961,328 Added 81.86%	4,357,426 $97.9 Million
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $44.8 Million - $65.4 Million	1,670,898 Added 230.41%	2,396,098 $72.1 Million
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $21.4 Million - $27.8 Million	725,200	725,200 $27.3 Million

Others Institutions Holding ACAD

# of Institutions

351

Shares Held

164M

Call Options Held

751K

Put Options Held

274K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.84B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account